HCAL
IBRX icon

HURRICANE CAPITAL ADVISORS LLC’s ImmunityBio IBRX Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.7K Buy
+7,500
New +$56.8K 0.02% 551
2024
Q3 		– Sell
-16,000
Closed -$101K – 587
2024
Q2 		$101K Buy
+16,000
New +$105K 0.04% 304

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's IBRX Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC opened a new position in ImmunityBio (IBRX) in Q2 2026: 7,500 shares worth $65.7K. The stake represents 0.02% of the portfolio and ranks #551 among its holdings. This is a return to the name: HURRICANE CAPITAL ADVISORS LLC previously reported a position in IBRX as recently as Q2 2024.

HURRICANE CAPITAL ADVISORS LLC first reported a position in IBRX in Q2 2024 and has held it in 2 quarters since. The position peaked at $101K in Q2 2024. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 7,500 shares of ImmunityBio worth $65.7K as of Q2 2026.
  • ImmunityBio was a new HURRICANE CAPITAL ADVISORS LLC position in Q2 2026.
  • ImmunityBio made up 0.02% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #551 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in ImmunityBio in Q2 2024 and has held it in 2 quarters since.
  • HURRICANE CAPITAL ADVISORS LLC's ImmunityBio position peaked at $101K in Q2 2024.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.